First Capital Bank donates to Parirenyatwa Hospital

ROBIN PHIRI

First Capital Bank, a publicly traded financial services provider, has donated essential cancer medication to Parirenyatwa Group of Hospitals, enhancing access to treatment for underserved patients.
The donation, valued at US$5 000, includes 110 vials of Paclitaxel and 10 doses of 10.8mg Zoladex, critical drugs for treating ovarian, prostate, and breast cancer.
These medications are expected to benefit up to 120 patients, depending on individual treatment needs.
Speaking at the handover ceremony, First Capital Bank Chief Executive Officer Tapera Mushoriwa reaffirmed the bank’s commitment to improving healthcare access.
“We are honored to be part of this noble cause,” Mushoriwa said.
“At First Capital Bank, we believe everyone deserves access to quality healthcare, regardless of their background or financial status.”
The donation aligns with First Capital Bank’s broader social impact initiatives, reinforcing its commitment to sustainable community support. The bank continues to explore and invest in strategic programs that improve healthcare access and drive meaningful change in Zimbabwe and beyond.
Parirenyatwa Group of Hospitals welcomed the donation, emphasizing its role in bridging critical gaps in cancer treatment accessibility.
Dr. Anna Nyakabau, Founder and Chairperson of CancerServe Trust, commended First Capital Bank’s commitment to the fight against cancer.
“The fight against cancer requires all of us to play a part,” Dr. Nyakabau said.
“First Capital Bank has taken an important step in ensuring more patients receive the treatment they need.”